Author:
Driessen Ann,Geboes Karen Paula,Dewit Olivier,Jouret-Mourin Anne
Publisher
Springer International Publishing
Reference48 articles.
1. Pulusu SSR, Lawrance IC. Dysplasia and colorectal cancer surveillance in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2017;11(8):711–22.
2. Ou B, Zhao J, Guan S, Lu A. Survival of colorectal cancer in patients with or without inflammatory bowel disease: a meta-analysis. Dig Dis Sci. 2016;61(3):881–9.
3. Bye WA, Nguyen TM, Parker CE, Jairath V, East JE. Strategies for detecting colon cancer in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2017;9:CD000279.
4. Geboes K, Rutgeerts P. Dysplasia in inflammatory bowel diseases: definition and clinical impact. Can J Gastroenterol. 1999;13(8):671–8.
5. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14(11):931–68.